共 25 条
[3]
Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA
[J].
CLINICOECONOMICS AND OUTCOMES RESEARCH,
2019, 11
:271-282
[6]
Cho K, 2019, DIABETES METAB J
[8]
Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI [10.1007/s00125-018-4729-5, 10.2337/dci18-0033]
[9]
Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
[J].
DIABETES OBESITY & METABOLISM,
2017, 19 (12)
:1798-1804
[10]
Twice-daily insulin degludec/insulin aspart effectively improved morning and evening glucose levels and quality of life in patients previously treated with premixed insulin: an observational study
[J].
DIABETOLOGY & METABOLIC SYNDROME,
2018, 10